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A bstract. Medical critiquing systems criticise clinical actions performed 
by a physician. In order to provide useful feedback, an important task is 
to find differences between the actual actions and a set of ‘ideal’ actions 
as described by a clinical guideline. In case differences exist, insight to 
which extent they are compatible is provided by the critiquing system.
We propose a methodology for such critiquing, where the ideal actions 
are given by a formal model of a clinical guideline, and where the ac­
tual actions are derived from real world patient data. We employ model 
checking to investigate whether a part of the actual treatment is con­
sistent with the guideline. Furthermore, it is shown how critiquing can 
be cast in terms of temporal logic, and what can be achieved by using 
model checking. The methodology has been applied to a clinical guideline 
of breast cancer in conjunction with breast cancer patient data.
1 Introdu ction
There is an increasing interest amongst researchers to  develop computerised 
versions of clinical guidelines, which at the moment are still just documents, 
using one of the specialised guideline representation languages. The resulting 
computer-based guidelines can then act as a basis for the development of decision- 
support systems, which, thus, allow computer-based deployment of guidelines in 
a clinical setting. One possible application of such clinical decision-support sys­
tems is critiquing, i.e., to  spot and analyse differences between the proposed 
actions taken by a medical doctor, and a set of ‘ideal’ actions as prescribed by 
the computerised guideline. As a computer-based clinical guideline is represented 
in a formal language, there is, also room for a formal underpinning of the various 
ways a guideline can be manipulated.
A natural way to  formally describe the actions taken by a medical doctor 
in the management of the disease of a patient is offered by temporal logics. As 
a family of languages, logics make it possible to  describe the meaning of the
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various aspects of the disease and condition of the patient in a precise fashion. 
By the addition of temporal operators, temporal logic adds various notions of 
progress of the disease and sequencing of actions in time.
One way to  look upon a patient and a patien t’s disease logically is as a con­
current system, i.e., as a system described in terms of states and state transitions 
in time. Model checking technology offers methods th a t allow one to  analyse con­
current systems for their consistency. One can rely on an extensive collection of 
tools and techniques readily available. It is a well investigated technique for ver­
ification of systems th a t can be modelled by a finite transition system. However, 
model checking has been mainly applied to  technical systems, such as hardware, 
software-based communication protocols, concurrent programs, etc. This raises 
the question when adopting this global view on the representation of diseases, 
patient conditions, and disease management actions, whether model checking 
can be used as a basis for critiquing. It is this question th a t is being explored in 
detail in this paper.
Model checking takes domain knowledge, called a system description, and 
sequences of actions as input. In this case, a formalised guideline is taken as a 
system description; the actions tha t have been performed on a specific patient are 
represented as a temporal formula. Model checking then involves investigating 
the consistency of the formalised guideline and actual treatm ent. The exploration 
of the use of model checking in the analysis of medical knowledge (guidelines and 
patient data) with the purpose of critiquing, is the innovative part of this work.
2 A pproach
The common feature of a critiquing system is th a t the user of the system provides 
as input (1) a problem description (e.g., patient symptoms), and (2) a proposed 
solution (e.g., a treatm ent plan). This second input is what distinguishes cri­
tiquing systems from the more traditional expert systems, which only take a 
problem description as input [10,4]. The second input to  a critiquing system, 
i.e., a proposed solution, is typically the output of an expert system.
In our approach of critiquing medical treatm ent plans using model checking, 
the input to  the system consists of patient data and a treatm ent plan (cf. Fig. 1). 
Patient data consists of patient symptoms and test outcomes measured for the 
patient, whereas the treatm ent plan consists of all actions (to be) performed by 
the practitioner. As the critiquing process is difficult to  accept by practitioners 
when they are continually interrupted to  provide input to  the system, both 
patient data and treatm ent plan are typically provided by electronic records. 
We will assume tha t these are given to  the system as temporal logic formulas.
The critiquing system uses the patient data and treatm ent plan as specifi­
cations tha t need to  be checked against a formal model of the guideline, i.e., a 
state transition system. When the specifications are consistent with the guide­
line model, no critique needs to  be generated as the proposed treatm ent plan 
conforms with the guideline. In case an inconsistency is found between the spec­
ification and the guideline model, the specification is weakened to  get insight to
Fig. 1. Critiquing approach using model checking. Given patient data and a treatment 
plan as input (temporal specifications), the critiquing system uses a model checker to 
verify consistency w.r.t. to a guideline model (state transition system) to generate a 
critique (empty in case of compliance).
which extent the treatm ent plan is consistent with the guideline. There are two 
possible reasons for the incompatibility:
Non-compliant order: It is possible tha t each of the actions in the treatm ent 
plan can be applied to  this patient, but only in a different order than  the 
treatm ent plan proposes. This can be established by removing the order 
between some of the actions in the treatm ent plan.
Non-compliant actions: Another possibility is that, according to  the guide­
line, some of the actions cannot be prescribed at all for the patient in ques­
tion. This can be investigated by considering a subset of the actions in the 
treatm ent plan.
The approaches can be combined and lead to  further insight into the nature of 
the detected inconsistency allowing the system to exploit these insights into a 
critique, which is then given to  the practitioner.
3 T em poral Logic for C ritiquing
In Subsection 3.1, the formal preliminaries of temporal logic are introduced. In 
Subsection 3.2, temporal logic is applied to  critiquing and examples are provided.
3.1 Preliminaries
Temporal logic is a modal logic, where relationships between worlds in the usual 
possible-world semantics of modal logic is understood as time order. The logic 
tha t we use here for specifying properties of medical guidelines is a combination 
of Computation Tree Logic (CTL) and Linear Temporal Logic (LTL) [3].
In this paper we model a guideline as a Kripke structure M  over a set 
of atomic propositions A P , which formally is defined as a four tuple M  =  
(S, S0,R , L) where S is a finite set of states, S0 C S is the set of initial states, 
R  C S x S is a to tal transition relation, and L : S ^  2AP is a function tha t
labels each state with the set of atomic propositions true in th a t state. A path 
in the model M  from a state s is an infinite sequence n  =  s0s is 2 . . .  such tha t 
s0 =  s and R (si ,s i+i) holds for all i > 0. W ith we denote the suffix of n 
starting at Sj.
CTL uses atomic propositions, propositional connectives, path quantifiers 
and temporal operators for describing properties of computation trees, i.e., the 
tree th a t is formed by designating a state in the Kripke structure as the initial 
state and then unwinding the structure into an infinite tree according to  the 
transition relation R  with the initial state as root. This leads to  two types of 
formulas: state formulas, which are true in a specific state, and path formulas, 
which are true along a specific path. A path formula is build up by applying one 
of the temporal operators to  one or two state formulas. In this paper, the three 
temporal operators used are X, G , and F. W ith X<^> being true if holds in the 
next state, G ^  if holds in the current state and all future states, F ^  if holds 
in the current state or some state in the future. A state formula can be built 
inductively from atomic propositions, propositional connectives, and if ƒ and g 
are path formulas, then E f  and A ƒ are state formulas. The path quantifiers A 
and E  are used to  specify th a t all of the paths or some of the paths starting at 
a specific state have some property.
The semantics of CTL is defined with respect to  a Kripke structure M . Given 
a state formula ƒ, the notation M, s =  ƒ denotes th a t ƒ holds in state s of the 
Kripke structure M . Assuming tha t ƒ  and ƒ2 are state formulas and g1 and 
g2 are path formulas, the relation =  is defined inductively as shown in Fig. 2. 
The remaining syntax consisting of V, F , G , A can be defined as usual, i.e., 
i ’l V i ’2 =  — (—A A — i ’i ^  i ’2 =  —A V G g =  and A J  =  - E ^ .
In contrast to  CTL, LTL provides operators for describing events along a 
single computation path. Each formula is of the form A ƒ, with ƒ being a path 
formula, which is either an atomic proposition or inductively defined as —I ƒ, ƒ Vg, 
ƒ A g, Xƒ, F ƒ , G ƒ, with ^ g  path formulas. This language can be evaluated on 
Kripke structures presented in Fig. 2.
M, s =  p ^  p € L(s)
M, s =  — fi M, s =  fi
M, s =  f 1 A f2 ^  M, s =  f 1 and M, s |= f 2
M, s =  Eg1 there is a path n from s such that M, n =  g1
M, n =  f 1 s is the first state of n and M, s =  f 1
M, n =  —g1 ^  M, n =  g1
M, n =  g1 A g2 M, n =  g1 and M, n =  g2
M, n =  Xg1 M, n 1 =  g1
M, n =  Fg1 ^  there exists a k > 0 such that M, n k =  g1
Fig. 2. Semantics of temporal logic with f 1 and f2 representing state formulas and g1 
and g2 representing path formulas.
3.2 Critiquing formulas
Each path in the state transition system can be considered a patient who is 
given a treatm ent th a t is consistent with the recommendation described by the 
guideline. Global properties of the guideline can be checked using LTL formulas 
or CTL formulas starting with A, for example, ‘A F  radio-therapy’, denotes tha t 
in each possible treatm ent, somewhere in the future radio-therapy is applied.
In the context of critiquing, CTL properties always start with an E, i.e., it is 
established th a t som e treatm ent path exists in the guideline where the proposed 
treatm ent is described. For example, abstracting from the patient, a treatm ent 
given by a sequence of actions a 1, a 2, . . .  can then be represented as:
E F (a 1 A E X E F  (a 2 A E X  E F  ( ...)))  (1)
i.e., in some treatm ent a 1 is done, and after tha t a 2, etc. In general, CTL 
model checking is more efficient than  LTL model checking, however, in case 
we do not know the order between the actions, a CTL formula consists of a 
disjunction of each possible order of actions and considers the existence of each 
order. In case of n actions, with all order unknown, this leads to  formulas of 
size O(n x 2n). Similarly, when global properties of the treatm ent path are 
introduced, for example the state of the patient or the fact th a t some action 
never occurs, such knowledge becomes difficult to  express. Assume for example 
a global property described by [ ,  then Formula (1) must be rephrased to  the 
rather complicated formula:
E ( [  U  ( a  A [  A E X  E ( [  U  (a 2 A [  A E X E ( . . .  A E G  [)))))  (2)
i.e., [  holds until at some point a 1 and [  (still) holds, after which [  holds, etc.
Usually, the knowledge is reasonably complete and the global information is 
sparse, however, for a more succinct representation we can either use a more 
expressive logic such as CTL* [3] or consider LTL model checking. An approach 
using LTL is modular model checking [6], where the model is restricted using an 
LTL formula to  those traces where the formula is valid. To prove the existence 
of a treatm ent in this approach, it is required to  verify th a t the model restricted 
to  a specification of a certain patient and treatm ent is not empty. Let be an 
LTL formula and [<^]M(±) denote th a t the set of LTL assertions leads to  an 
empty model, i.e., describes a trace not present in the model. In contrast, if 
[<^]M(±) is shown to be false, then M  can not be empty when restricted to  
proving th a t the trace described by exists in the model M . Formula (2) can 
thus be verified by showing tha t
[G [ A F ( a 1X F (a 2 A ...))]M  (±) (3)
is false . An additional benefit of this presention is th a t when order information 
is absent, the property is typically more intuitivly specified. Nonetheless, when 
there are few actions involved and much of the order information is present, CTL 
formulas are expected to  be more efficient to  verify.
4 A pp lication  o f th e  M eth od ology  to  B reast Cancer
4.1 Design and choice of case studies
The clinical guideline used is the Dutch breast cancer guideline3 and was rep­
resented as a state transition system in Cadence SMV using the techniques 
and representation described in [2]. The models used here were developed as 
part of the Protocure-II project.4 Patient data were obtained from the Dutch 
Comprehensive Cancer Centre South (CCC), a registry in the Netherlands used 
for cancer research, planning of services, and evaluation and implementation of 
guidelines. The data collected concerns breast cancer patients treated in the pe­
riod January 2003 - June 2004, when the guideline was applicable, and therefore 
suitable for compliance checks with the guideline. Each patient record consists 
of 269 variables, which includes information about the diagnosis and treatm ent.
The patient data from the registry could, in principle, directly be used for 
critiquing w.r.t. to  the guideline. However, matching such data records to  the 
terminology of the guideline is hard [7] and differs from the course commonly fol­
lowed in medicine. In medical literature, specific patient cases, called casuistics, 
are frequenly discussed in detail to  gain insight into the way the patien t’s disease 
was managed. These papers follow a long standing tradition and are seen as part 
of the ‘education permanente’ of the medical profession. Critiquing in this paper 
was therefore done casuistically by having the CCC patient data interpreted by 
medical experts who provided a direct mapping from the patient data in the 
registry to  the guideline. Subsection 4.2 presents in more detail a case-study in 
critiquing using the casuistic interpretation of the CCC data.
A second case-study is presented in Subsection 4.3, which was obtained from 
the New South Wales Breast Cancer Institute, Australia.5 These studies have 
been developed from the casuistic point of view to “allow clinicians, health pro­
fessionals and members of the public to  examine and understand some of the 
controversial and difficult aspects of breast cancer management” . They are there­
fore more detailed than  the patient data collected by the registry and are more 
suitable for an investigation of critiquing from a clinical point of view.
4.2 Case study 1: ductal carcinoma in situ
The steps of critiquing on one specific patient derived from the data, and sub­
sequently interpreted by medical experts, is illustrated here. The diagnosis and 
treatm ent is summarised in Fig. 3. It can be said th a t this is a rather typical 
patient as it is a patient with one of the most frequent diagnoses in the data 
records. The following property describes the treatm ent sequence th a t our ex­
ample patient has undergone. “For a patient with diagnosis Ductal Carcinoma 
In  S itu  (DCIS), the following sequence o f states is possible: the treatm ent starts, 
then axillary staging by sentinel node is activated, after which breast conserving
3 CBO: Richtlijn Behandeling van het mammacarcinoom, van Zuiden, 2002
4 Breast cancer model can be obtained from http://www.protocure.org
http://www.bci.org.au/medical/caseindex.htm
M edical condition: 79 years-old woman. Lesion of 
right breast: carcinoma in-situ with size between 1 and
2 cm. Two lymph nodes investigated and none positive. 
T reatm ent: sentinel node biopsy +  breast-conserving 
surgery without axillary clearance.
Fig. 3. Description of patient in conjunction with the prescribed treatment.
therapy is activated”. To specify and then verify th a t breast conserving therapy 
(denoted bct) can take place after axillary staging by sentinel node procedure 
(denoted asbSN), the following CTL formula is used:
EF(DCIS A E X  EF(asbSN  A E X  E F  bct))
A more strict formula could be obtained by assuming th a t the diagnosis DCIS, 
holds up to  the moment of breast conserving therapy. However, this property 
stated above turns out to  be false as it is, i.e., this treatm ent is non-compliant 
with respect to  the guideline. In other words, according to  the model of the 
guideline describing the treatm ent of DCIS, the sequence of actions performed 
by the doctor is incorrect for this patient. It could also be explained by the fact 
that, according to  the model, at least one of the two actions in patient treatm ent 
should not be started, or they should be started in a different sequence. To 
identify this inconsistency, we reduce the actions th a t are being performed. If 
we reduce the sequence to  only one action, then both actions are found possible, 
as shown by the following property (corresponding to  the case when only ‘b c t’ 
is activated as part of the DCIS treatm ent):
EF(DCIS A E X  E F  bct)
The new conclusion is th a t under these circumstances the two actions cannot be 
activated in this sequence, or the ordering should be reversed.
In the experiment on the seven fairly prototypical patient-cases th a t can 
be found in the Dutch CCC data-set, some deviation was found between the 
guideline and each of the seven prototypical cases. Interestingly, for three of 
these, some differences could indeed be explained by looking at the new 2004 
revision of the guideline.
4.3 C ase  s tu d y  2: in f iltra tin g  d u c ta l  ca rc in o m a
For the second case study we have more elaborate information available. It con­
cerns a patient who is a female with a lump in the 3 o’clock position of the right 
breast and a second lump just above this. No palpable axillary nodes or other 
abnormalities were found. The mammography revealed no focal mass, grouped 
microcalcifications, or anatomic distortion. Finally, the histopathology showed 
two lesions: both infiltrating duct carcinoma, 20mm in size, and with similar
morphology. The sentinel nodes were mapped using lymphoscintigraphy and a 
biopsy was taken of a right axillary lymph node and an internal mammary node 
(the sentinel node procedure). In the right axillary lymph node, no malignancy 
was found. However, in the internal mammary node, m etastatic carcinoma was 
identified. The treatm ent consisted of a total mastectomy of the right breast 
with immediate reconstruction. The axilla was treated by means of an axillary 
clearance and re-section of two further internal mammary nodes at higher levels 
(these were sampled partly because of the original pathology finding and partly 
because of ready access to  the IMC).
The vocabulary of the guideline does not include the term  ‘infiltrating ductal 
carcinoma’, but rather discusses ‘operable invasive breast cancer’ (OIBC). Ac­
cording to  the guideline, operable invasive breast cancer is defined as T1-2 N0-1 
M0, i.e., a tum our smaller than  5cm, with maximally one lymph node positive, 
and no distant metastasis. On basis of information provided by the diagnostic 
tests, the patient can be considered part of this patient group. Each of the three 
interventions (sentinel node procedure, mastectomy, and axillary clearance) can 
be mapped to  terms found in the guideline. This can be done with reasonable 
confidence, however, some details have to  be ignored such as the re-section of 
the internal mammary nodes as part of the axillary clearance, as this part of 
the treatm ent is not mentioned in the guideline. W ith respect to  the order be­
tween interventions, it is only clear th a t the sentinel node procedure (asbSN) is 
performed before the other two interventions.
The treatm ent can again be critiqued using a CTL proof obligation, but as 
some of the information is missing here, we illustrate critiquing using modular 
model checking. The proof obligation is then described by [p]M (±) where
p  =  G OIBC A F (asbSN A X(F axillary-clearance A F mastectomy))
The proof obligation [p]M (±) is true, showing th a t this combination of inter­
ventions is not possible (cf. Subsection 3.2). The reason for this can be further 
analysed by removing one of the order constraints yielding
p ' =  G OIBC A F asbSN A F axillary-clearance A F mastectomy
As [p']M (±) is true, the formula p ' is further weakened by removing one of 
the interventions from the conjunct. This results in three new proof obligations, 
showing th a t the guideline model does not contain a trace with both a sentinel 
node procedure and axillary clearance for this patient, while all other combi­
nations appear to  be possible. Thus, the conclusion is th a t the combination of 
actions th a t are being prescribed is non-compliant with respect to  the guideline.
5 R elated  W ork
The use of the term  critiquing to  describe a system tha t criticises the so­
lution provided by a human can be attributed to  Miller [8], who developed 
his ATTENDING system for critiquing anaesthesia management. Although cri­
tiquing has first been used for evaluating medical treatm ent plans, since then
it has been applied to  a wide variety of problems such as engineering design, 
decision making, word processing, knowledge base acquisition, and software en­
gineering [10]. At the end of the 1990s, when several guideline representation 
languages were introduced, critiquing using guidelines became a topic of inter­
est, e.g., the approach of Shahar et al. [9]. In contrast with previous work, in 
this approach the patient states are considered for critiquing, besides the physi­
cian’s actions. Advani et al. [1] argued th a t a critiquing system should adjust 
its critique for cases when the physician’s actions are following the spirit and 
overall goals or intentions of the guideline designers, even though the actions de­
viate from the guideline. However, in [7], a case study showed th a t intentions of 
the protocol are often implicit and moreover, the intentions reported by experts 
almost always differ, which makes it hard to  model. Recently, there was some 
progress to  overcome this difficulty [11], which might be interesting to  integrate 
in our proposed methodology. Using model checking for verifying properties of 
formalised medical guidelines is very recent [12,2].
6 C onclusions
The main conclusion of this work is th a t it is, in principle, possible to  use model 
checking on formalised models in order to  critique medical guidelines against 
patient data. We have shown how critiquing can be characterised in temporal 
logic and have applied this to  a case study on the treatm ent of breast cancer. The 
strong aspect of this technology is the high degree of automation as compared 
to  theorem proving, making it suitable for deployment in a critiquing system.
Model checking provides additional value to  a simulation-based critiquing of 
an operational version of the guideline. Such critiquing based on running the 
operational guideline model through an interpreter only checks the consistency 
of a patient record against a single trace through the guideline (namely, the one 
chosen by the interpreter), while model checking compares the patient record 
against all possible traces through the guideline. This difference is crucial when 
the guideline is under-specified [5], which is usually the case, and therefore con­
tains non-deterministic choices between treatments.
The fully autom ated nature of model checking also brings a weakness with 
it: model checking only detects inconsistencies, but does not contribute to  the 
interpretation of the inconsistency. In general, model checking can construct a 
counter-example illustrating the inconsistency, which is often a very good guide 
towards tracing its source. However, this only works when model checking global 
properties, i.e., properties dealing with all possible treatm ent paths, while in Sec­
tion 3 we argue th a t critiquing deals with formulas tha t establish the existence of 
a single treatm ent, thereby making it impossible for the model checker to  gener­
ate a counter-example. In this paper, we have proposed some general strategies 
to  deal with this (repeated experiments with weaker specifications by relaxing 
order constraints and by removing actions).
A general conclusion with respect to  the breast cancer case study th a t can 
be drawn is th a t a closer correspondence is needed between the processes of
guideline construction and data-collection. In fact, this is currently already be­
ing partially implemented by the Dutch Institute of Healthcare Improvement: 
newly constructed guidelines are currently being equipped with a data-collection 
dictionary, which will ensure the correspondence between collected data and 
guideline terminology.
Even though the steps in the analysis of the case studies was done manually, 
it is not difficult to  see how to automate this process since the temporal formu­
las could be generated mechanically. A more challenging question is how to  use 
the result of this process for the construction of a human readable critique. In 
evidence-based guidelines, explanation and references are often provided, how­
ever, formal models of guidelines often abstract from this information making it 
difficult to  provide elaborate information to  the practitioner. This is an interest­
ing topic for future research.
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